Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Concentration Cells02:41

Concentration Cells

25.9K
A concentration cell is a type of a  voltaic cell constructed by connecting two almost identical half-cells, both based on the same half-reaction and using the same electrode, differing only in the concentration of one redox species. A concentration cell's potential, therefore, is determined only by the concentration difference of the particular redox species.
Consider the following voltaic cell:
25.9K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

6.9K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.9K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

3.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.2K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

731
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
731
Solution Concentration and Dilution02:59

Solution Concentration and Dilution

133.8K
The relative amount of a given solution component is known as its concentration. Often, though not always, a solution contains one component with a concentration that is significantly greater than that of all other components. This component is called the solvent and may be viewed as the medium in which the other components are dispersed or dissolved. Solutions in which water is the solvent are, of course, very common on our planet. A solution in which water is the solvent is called an aqueous...
133.8K
Stress Concentrations01:13

Stress Concentrations

635
The concept of stress concentration is crucial for understanding how materials respond under bending stresses, particularly when there are irregularities or discontinuities in the material's geometry. Normally, stress in a symmetric member subjected to pure bending is assumed to be uniformly distributed across the entire cross-section. However, this assumption does not hold when there are variations in the cross-sectional geometry or the presence of notches and holes.
The stress...
635

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insulin Sensitivity and Beta Cell Function With Macupatide Alone or With Dulaglutide in Type 2 Diabetes: A Phase 1b, Randomised Controlled Trial.

Diabetes, obesity & metabolism·2026
Same author

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Petrelintide for Weight Management: Two Randomized, Controlled Phase 1 Trials.

Diabetes, obesity & metabolism·2026
Same author

Personal viewpoint: Risk stratification and counseling of living kidney donor candidates with prediabetes.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Characterisation of steady-state pharmacokinetics and glucodynamics of once-weekly insulin efsitora alfa in individuals with type 2 diabetes.

Diabetes, obesity & metabolism·2026
Same author

Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial).

European heart journal·2025
Same author

Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trial.

European journal of heart failure·2025

Related Experiment Video

Updated: Jan 31, 2026

Best Current Practice for Obtaining High Quality EEG Data During Simultaneous fMRI
10:35

Best Current Practice for Obtaining High Quality EEG Data During Simultaneous fMRI

Published on: June 3, 2013

33.3K

Concentrated insulins in current clinical practice.

Nanette C Schloot1, Robert C Hood2, Sheila M Corrigan3

  • 1Lilly Deutschland GmbH, Werner-Reimers-Str. 2-4, 61352 Bad Homburg, Germany.

Diabetes Research and Clinical Practice
|December 25, 2018
PubMed
Summary
This summary is machine-generated.

New concentrated insulins and devices offer improved diabetes management by reducing injection volume and frequency. This review details their unique properties to aid healthcare providers and patients in optimal utilization.

Keywords:
ConcentratedDiabetesInsulinPharmacokineticPrandial

More Related Videos

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.4K
Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster
05:52

Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster

Published on: June 30, 2011

20.4K

Related Experiment Videos

Last Updated: Jan 31, 2026

Best Current Practice for Obtaining High Quality EEG Data During Simultaneous fMRI
10:35

Best Current Practice for Obtaining High Quality EEG Data During Simultaneous fMRI

Published on: June 3, 2013

33.3K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.4K
Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster
05:52

Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster

Published on: June 30, 2011

20.4K

Area of Science:

  • Endocrinology
  • Pharmacology
  • Diabetes Management

Background:

  • Concentrated insulins (exceeding 100 units/mL) and specialized delivery devices are now available.
  • These offer novel therapeutic options for both basal and prandial insulin supplementation in diabetes.
  • Formulations vary from 2-fold (insulin lispro 200 units/mL) to 5-fold (human regular insulin 500 units/mL) concentrations.

Purpose of the Study:

  • To review the distinct characteristics of various concentrated insulin formulations.
  • To guide healthcare providers and individuals with diabetes in the effective use of these advanced therapies.
  • To highlight how concentrated insulins aim to simplify insulin regimens.

Main Methods:

  • Literature review of concentrated insulin products and associated delivery systems.
  • Analysis of pharmacokinetic and pharmacodynamic properties where altered.
  • Summary of clinical applications for basal and prandial insulin needs.

Main Results:

  • Concentrated rapid-acting insulins (e.g., insulin lispro 200 units/mL) facilitate prandial coverage.
  • Concentrated short-acting insulins (e.g., human regular insulin 500 units/mL) support basal and prandial needs.
  • Long-acting basal insulins include degludec 200 units/mL and glargine 300 units/mL, offering extended duration.

Conclusions:

  • Concentrated insulins reduce injection volume and potentially frequency, enhancing patient convenience.
  • Understanding the specific properties of each concentrated insulin is crucial for optimizing diabetes treatment.
  • These advancements represent a significant evolution in insulin therapy for managing blood glucose levels.